POMBILITI

AMICUS THERAPEUTICS US, LLC🇺🇸 United States

FDA Page

Effective Date: Aug 12, 2026
Approval ID: d77aa596-910d-516b-e053-2995a90a0839
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use POMBILITI safely and effectively. See full prescribing information for POMBILITI. POMBILITI (cipaglucosidase alfa-atga) for injection, for intravenous use Initial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.